<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2026-13821">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2026_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2026-07-08</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Schedules of Controlled Substances: Placement of Tianeptine in Schedule I</title>
        <partName>Proposed Rules</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2026-07-08/html/2026-13821.htm">
        <identifier type="FDsys Unique ID">D09002ee1e4949c51</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2026-07-08/pdf/2026-13821.pdf">
        <identifier type="FDsys Unique ID">D09002ee1e4949caf</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Justice</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Drug Enforcement Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine.</abstract>
    <identifier type="FR citation">91 FR 42150</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2026-07-08/2026-13821</identifier>
    <identifier type="FR Doc No.">2026-13821</identifier>
    <identifier type="former granule identifier">fr08jy26-7</identifier>
    <identifier type="billing code">4410-09-P</identifier>
    <identifier type="department code">Docket No. DEA1596</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2026-07-08/2026-13821</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2026-07-08/html/2026-13821.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2026-07-08/pdf/2026-13821.pdf</url>
    </location>
    <subject>
        <topic>Administrative Practice and Procedure</topic>
        <topic>Drug Traffic Control</topic>
        <topic>Reporting and Recordkeeping Requirements</topic>
    </subject>
    <physicalDescription>
        <extent>9 p.</extent>
    </physicalDescription>
    <part type="Proposed Rules">
        <extent unit="pages">
            <start>42150</start>
            <end>42158</end>
        </extent>
    </part>
    <identifier type="preferred citation">91 FR 42150</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1308</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1308</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Schedules of Controlled Substances: Placement of Tianeptine in Schedule I; Federal Register Vol. 91, Issue </searchTitle>
        <granuleClass>PRORULE</granuleClass>
        <accessId>2026-13821</accessId>
        <agency order="1">DEPARTMENT OF JUSTICE</agency>
        <agency order="2">Drug Enforcement Administration</agency>
        <commentDate>2026-08-07</commentDate>
        <departmentDoc>Docket No. DEA1596</departmentDoc>
        <billingCode>4410-09-P</billingCode>
        <frDocNumber>2026-13821</frDocNumber>
        <action>Notice of proposed rulemaking.</action>
        <summary>The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine.</summary>
        <dates>Comments must be submitted electronically or postmarked on or before August 7, 2026. The electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.</dates>
        <contact>Dr. Terrence L. Boos, Drug and Chemical Evaluation Section, Diversion Control Division, Drug Enforcement Administration; Telephone: (571) 362-3249.</contact>
        <cfr title="21">
                                    
            <part number="1308"/>
                                    
            <subject>Administrative Practice and Procedure</subject>
                                    
            <subject>Drug Traffic Control</subject>
                                    
            <subject>Reporting and Recordkeeping Requirements</subject>
                                
        </cfr>
        <tocSubject1>Schedules of Controlled Substances</tocSubject1>
        <tocDoc>Placement of Tianeptine in Schedule I, </tocDoc>
        <urlRef>http://www.regulations.gov</urlRef>
        <urlRef>https://scifinder.cas.org</urlRef>
        <urlRef>https://www.aapcc.org/data-system/</urlRef>
        <urlRef>https://www.census.gov/data/tables/2021/econ/susb/2021-susb-annual.html</urlRef>
        <urlRef>https://www.census.gov/naics/reference_files_tools/2022_NAICS_Manual.pdf</urlRef>
        <urlRef>https://www.fda.gov/consumers/health-fraud-scams/new-gas-station-heroin-tianeptine-product-trend</urlRef>
        <urlRef>https://www.regulations.gov</urlRef>
        <urlRef>https://www.sba.gov/sites/default/files/2023-06/Table%20of%20Size%20Standards_Effective%20March%2017%2C%202023%20%282%29.pdf</urlRef>
        <urlRef>www.regulations.gov</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee1e49377a5" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2026-07-08/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 91, no. 129</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2026-07-08</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>185 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2026-07-08">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2026-07-08</identifier>
        <identifier type="local">P0b002ee1e49377a5</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr08jy26</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2026-07-08</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2026-07-08/pdf/FR-2026-07-08.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2026-07-08/xml/FR-2026-07-08.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>42135</start>
                <end>42311</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2026-07-08</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2026-07-08</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2026-07-08</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2026-07-08</accessId>
            <volume>91</volume>
            <issue>129</issue>
        </extension>
    </relatedItem>
</mods>
